> CVE-2026-15415 [MEDIUM]

« BACK_TO_HOME
PUBLISHED
2026-07-17 20:17
MODIFIED
2026-07-17 20:17
CVSS_SCORE V3
6.8
EPSS (Prob. Exploit)
0.35%
Top 72.2%
DATA SOURCES:
NVD đź”— 2026-07-17 CWE MITRE đź”— 2026-11-01 FIRST EPSS đź”— 2026-10-25

> DESCRIPTION

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

> AFFECTED_PRODUCTS

ℹ️ Aucun produit affecté n'a encore été publié par NVD pour cette CVE.

> CVSS V3 METRICS

CVSS_VECTOR
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

> MÉTRIQUES CVSS DÉTAILLÉES

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Métrique Valeur Interprétation
AV (Vecteur d'Attaque)
Attack Vector
Local (L)
Exploit nécessite un accès local au système
AC (Complexité d'Attaque)
Attack Complexity
Low (L)
Peu de conditions requises pour exploiter
PR (Privilèges Requis)
Privileges Required
None (N)
Aucune authentification requise
UI (Interaction Utilisateur)
User Interaction
Unknown (P)
Interaction inconnue
S (Périmètre)
Scope
Unchanged (U)
Impact reste dans le périmètre du composant compromis
C (Impact Confidentialité)
Confidentiality Impact
None (N)
Aucune divulgation d'informations
I (Impact Intégrité)
Integrity Impact
High (H)
Modification totale des données possible
A (Impact Disponibilité)
Availability Impact
None (N)
Aucune interruption de service

> RÉSUMÉ DES IMPACTS

Confidentialité
None
Aucune divulgation d'informations
Intégrité
High
Modification totale des données possible
Disponibilité
None
Aucune interruption de service

> WEAKNESSES

CWE-23

> CWE DETAILED DESCRIPTIONS

CWE-23: Relative Path Traversal - The product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize sequences such as ".." that can resolve to a location that is outside of that directory.

> HISTORIQUE DES MODIFICATIONS

Première apparition
17/07/2026 20:17
Source: NVD
📊 ENRICHISSEMENT 01/08/2026 06:01
CWE
Champ modifié: Description CWE
Ancienne valeur:
N/A
Nouvelle valeur:
CWE-23: Relative Path Traversal - The product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize sequences such as ".." that ...
Total des modifications: 1 Dernière mise à jour: 3 months ago

> REFERENCES

https://aws.amazon.com/security/security-bulletins/2026-060-aws/
https://github.com/awslabs/mcp/security/advisories/GHSA-6x7f-488g-75wm
https://pypi.org/project/awslabs.aws-healthomics-mcp-server/0.0.36/
« BACK_TO_HOME